January 20, 2026

Premier, Inc. (PINC) Investor Outlook: Navigating the 2.97% Dividend Yield Amidst Revenue Decline

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, specializes in health information services in the United States. With a market capitalization of $2.34 billion, Premier operates as..

Guardian Pharmacy Services, Inc (GRDN): Investor Outlook with 29% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN) is capturing investor attention with its remarkable potential upside of nearly 29.49%, according to analyst ratings. As a prominent player in the healthcare sector,..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Assessing 18% Potential Upside Amid Strategic Advancements

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, continues to capture investor interest with its strategic focus on developing treatments for central nervous system (CNS) disorders..

Vericel Corporation (VCEL) Stock Analysis: Unpacking a 47% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) stands out in the biotechnology industry with a compelling narrative centered around innovative cellular therapies and specialty biologic products. Headquartered in Cambridge, Massachusetts, Vericel is carving..

Mirum Pharmaceuticals, Inc. (MIRM) Investor Outlook: Robust Buy Ratings Signal Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands out in the biotechnology sector, focusing on the development of therapies for rare and orphan diseases. With a market capitalization of $4.71 billion, this..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Analyzing a Promising 114% Potential Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a prominent player in the biotechnology sector focusing on innovative eye care solutions, presents an intriguing opportunity for investors. With its current market cap standing..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 38.87% Potential Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a prominent player in the biotechnology sector, offers an exciting opportunity for investors eager to explore the healthcare industry’s potential for innovation and growth. Headquartered..

Metsera, Inc. (MTSR) Stock Analysis: Navigating the Biotech Waters with a -19.15% Potential Downside

Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its pioneering approach to addressing obesity and related disorders. Based in New York and now..

AdaptHealth Corp. (AHCO) Stock Analysis: A Promising 26% Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a crucial player in the healthcare sector, specializes in the distribution of home medical equipment and supplies across the United States. With a robust portfolio that..

SS Innovations International (SSII) Investor Outlook: Exploring the 192.5% Revenue Growth in India’s Booming Medical Device Sector

SS Innovations International Inc. (SSII), a key player in the healthcare sector, is making waves in the medical device industry with its rapid revenue growth and innovative surgical robotics technology...

Vera Therapeutics (VERA) Stock Analysis: Biotech with 61.59% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing the attention of investors with its promising potential upside of 61.59%. This clinical-stage biotechnology company is making waves in the healthcare sector with..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 108% Upside in Biotech Innovation

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its promising biopharmaceutical developments and a notable potential upside of 108.02%. As a key player in the biotechnology..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring its 36.88% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company based in Alhambra, California, is making waves in the medical care facilities industry. With a market capitalization of $1.35 billion, Astrana..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 22% Potential Upside in Biotech

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a dynamic player in the biotechnology sector, offers investors a compelling narrative with its strong revenue growth and promising pipeline of dermatological treatments. Headquartered in..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Riding the Biotech Wave with a 3.28% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a key player in the biotechnology sector, continues to capture investor interest with its innovative approach to treating rare diseases. Headquartered in Princeton, New Jersey,..

Ascentage Pharma Group (AAPG) Stock Analysis: Unpacking Its 69% Potential Upside

Investors keen on the biotechnology sector might find a compelling opportunity in Ascentage Pharma Group International (AAPG), particularly given its notable potential upside of 69%. This China-based clinical-stage biotechnology company,..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Powerhouse with 134% Upside Potential

In the ever-evolving landscape of biotechnology, Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a beacon of innovation and potential. As a clinical-stage company focused on developing therapeutics for neuromuscular..

Kestra Medical Technologies (KMTS): A Promising Healthcare Innovator with 26.91% Potential Upside

For investors seeking opportunities in the dynamic healthcare sector, Kestra Medical Technologies, Ltd. (KMTS) offers a compelling proposition with its innovative approach to cardiovascular care. Based in Kirkland, Washington, and..

LivaNova PLC (LIVN) Stock Analysis: Capitalizing on a 17.53% Potential Upside in the Healthcare Sector

LivaNova PLC (NASDAQ: LIVN), a key player in the healthcare sector, is drawing investor attention with a promising 17.53% potential upside, according to the latest analyst ratings. As a medical..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Unpacking the 14% Potential Upside

Adaptive Biotechnologies Corporation (ADPT), a pioneering entity in the biotechnology sector, stands at the forefront of immune medicine innovations. With its headquarters nestled in Seattle, Washington, the company is a..

Search

Funds

January 20, 2026

Search

Funds

January 20, 2026

FTSE 100

Funds